(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 9891.50 | 9660.80 | 2.39 | 37902.00 | 37234.90 | 1.79 | 37902.00 | 37234.90 | 1.79 |
| Other Income | 357.10 | 394.60 | -9.50 | 1425.60 | 1425.60 | 0.00 | 1425.60 | 1425.60 | 0.00 |
| PBIDT | 3829.00 | 3702.00 | 3.43 | 14427.60 | 13118.50 | 9.98 | 14427.60 | 13118.50 | 9.98 |
| Interest | 6.10 | 5.80 | 5.17 | 27.30 | 13.10 | 108.40 | 27.30 | 13.10 | 108.40 |
| PBDT | 3822.90 | 3696.20 | 3.43 | 14426.70 | 13152.30 | 9.69 | 14426.70 | 13152.30 | 9.69 |
| Depreciation | 131.70 | 147.20 | -10.53 | 664.40 | 667.90 | -0.52 | 664.40 | 667.90 | -0.52 |
| PBT | 3691.20 | 3549.00 | 4.01 | 13762.30 | 12484.40 | 10.24 | 13762.30 | 12484.40 | 10.24 |
| TAX | 941.80 | 947.60 | -0.61 | 3644.10 | 3293.80 | 10.64 | 3644.10 | 3293.80 | 10.64 |
| Deferred Tax | 69.40 | 54.20 | 28.04 | 94.60 | 62.00 | 52.58 | 94.60 | 62.00 | 52.58 |
| PAT | 2749.40 | 2601.40 | 5.69 | 10118.20 | 9190.60 | 10.09 | 10118.20 | 9190.60 | 10.09 |
| Equity | 1694.10 | 1694.10 | 0.00 | 1694.10 | 1694.10 | 0.00 | 1694.10 | 1694.10 | 0.00 |
| PBIDTM(%) | 38.71 | 38.32 | 1.02 | 38.07 | 35.23 | 8.04 | 38.07 | 35.23 | 8.04 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.25 |
| Dr. Reddys Labs. | 1245.50 |
| Cipla | 1438.75 |
| Zydus Lifesciences | 1150.50 |
| Lupin | 2496.05 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: